Acorda Therapeutics (ACOR) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-2.78
-1.66
-0.55
0.57

Details

Expected EPS
N/A
Actual EPS
-0.69
Surprise EPS
-0.69
Surprise Percent
+∞%

Description

Acorda Therapeutics (ACOR) has reported earnings of -0.69 per share for Q1 2023.

0 Comments

Share your thoughts